A minituarized disposable molecular diagnostics platform for combatting coronavirus infections

Project description

Novel diagnostic platform for COVID-19 rapid test

The EU-funded DECISION project is developing a new class of COVID-19 diagnostic platforms and tests in a joint effort by teams from Italy, Spain and Germany. The diagnostic platform will enable the rapid detection of COVID-19 infections on-site in any possible setting, including drive-through testing centres, airports or medical offices. The low-cost, miniature, disposable diagnostic platform is powered by a next-generation nucleic acid amplification technology called pulse controlled amplification (PCA®), providing sample-to-answer workflows in less than 15 minutes. The objective is to deliver the molecular diagnostic platform and coronavirus test within five months after the start of the project.

Fields of science

• medical and health sciences › health sciences › infectious diseases › RNA viruses › coronaviruses
• medical and health sciences › health sciences › public health › epidemiology › pandemics

Programme(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.7. - Innovative Medicines Initiative 2 (IMI2)

Topic(s)

• IMI2-2020-21-01 - Development of therapeutics and diagnostics combatting coronavirus infections

Call for proposal

H2020-JTI-IMI2-2020-21-single-stage

See other projects for this call

Funding Scheme

IMI2-RIA - Research and Innovation action

Coordinator

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Net EU contribution

€ 2 064 178,49

Address

Giefinggasse 4
1210 Wien
Austria

Activity type

Research Organisations

Non-EU contribution

€ 0,00

Region

Wien › Wien

Participants (4)

MICROLIQUID SL

Participation ended

Spain

Net EU contribution

€ 343 053,24

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes

Address

Avenida Uribarri 19-1 Saiolan
20500 Arrasate Mondragon

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Non-EU contribution

€ 0,00

Region

Noreste › País Vasco › Gipuzkoa

ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

Italy

Net EU contribution

€ 406 350,00

Address

Via Portuense, 292
00149 Roma

Activity type

Research Organisations

Non-EU contribution

€ 0,00

Region

Centro (IT) › Lazio › Roma

BUNDESMINISTERIUM DER VERTEIDIGUNG

Germany

Net EU contribution

€ 425 250,00

Address

Fontainengraben 150
53123 Bonn

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

Non-EU contribution

€ 0,00

Region

Nordrhein-Westfalen › Köln › Bonn, Kreisfreie Stadt

GNA BIOSOLUTIONS GMBH

Germany

Net EU contribution

€ 196 268,27

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes

Address

Am Klopferspitz 19
82152 Martinsried

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Non-EU contribution

€ 312 500,00

Region

Bayern › Oberbayern › München, Landkreis